Abstract
Aging is a complex irreversible biological process associated with increased prevalence of chronic disease and high healthcare burden. Several theories have been proposed for the biology of aging including free radical accumulation, DNA damage, apoptosis, telomere shortening, autophagy failure, and disturbed autonomic response. Aging is also closely associated with progressive deterioration of cardiovascular and neurological functions. Linkage, genome-wide association (GWAS), and next-generation sequencing analysis have confirmed a number of susceptibility loci for aging, in particular, Alzheimer’s disease. Recent evidence from our group and others also revealed a tie between genetic mutation of mitochondrial aldehyde dehydrogenase (ALDH2) and life span as well as cardiovascular aging. ALDH2 represents the single most gene with the greatest number of human genetic polymorphism and is deemed an important enzyme for detoxification of reactive aldehydes. Here, we will briefly review the tie between ALDH2 and cardiovascular aging process. While recent work on ALDH2 research has broadened the pathogenic mechanisms of ALDH2 mutation or deficiency, therapeutic potential targeting ALDH2 in the elderly still remains debatable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ren J, Sowers JR, Zhang Y (2018) Metabolic stress, autophagy, and cardiovascular aging: from pathophysiology to therapeutics. Trends Endocrinol Metab 29(10):699–711
Lutz W, Sanderson W, Scherbov S (2008) The coming acceleration of global population ageing. Nature 451(7179):716–719
Lakatta EG (1993) Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 73(2):413–467
Boengler K, Schulz R, Heusch G (2009) Loss of cardioprotection with ageing. Cardiovasc Res 83(2):247–261
Rich MW, Quality of Care C, Heart Failure Society of A (2011) The year in quality of care in heart failure. J Card Fail 17(6):443–450
Sen P, Shah PP, Nativio R, Berger SL (2016) Epigenetic mechanisms of longevity and aging. Cell 166(4):822–839
Hoshi H, Hao W, Fujita Y, Funayama A, Miyauchi Y, Hashimoto K, Miyamoto K, Iwasaki R, Sato Y, Kobayashi T, Miyamoto H, Yoshida S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Kitagawa K, Nakayama KI, Kawamoto T, Sano M, Fukuda K, Ohsawa I, Ohta S, Morioka H, Matsumoto M, Chiba K, Toyama Y, Miyamoto T (2012) Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis. J Bone Miner Res Off J Am Soc Bone Miner Res 27(9):2015–2023
Tosto G, Reitz C (2016) Genomics of Alzheimer’s disease: value of high-throughput genomic technologies to dissect its etiology. Mol Cell Probes 30(6):397–403
Barnes PJ (2015) Mechanisms of development of multimorbidity in the elderly. Eur Respir J 45(3):790–806
Hartl FU (2016) Cellular homeostasis and aging. Annu Rev Biochem 85:1–4
Chen CH, Sun L, Mochly-Rosen D (2010) Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovasc Res 88(1):51–57
Wang S, Wang C, Turdi S, Richmond KL, Zhang Y, Ren J (2018) ALDH2 protects against high fat diet-induced obesity cardiomyopathy and defective autophagy: role of CaM kinase II, histone H3K9 methyltransferase SUV39H, Sirt1, and PGC-1alpha deacetylation. Int J Obes (2005) 42(5):1073–1087
Wu B, Yu L, Wang Y, Wang H, Li C, Yin Y, Yang J, Wang Z, Zheng Q, Ma H (2016) Aldehyde dehydrogenase 2 activation in aged heart improves the autophagy by reducing the carbonyl modification on SIRT1. Oncotarget 7(3):2175–2188
Zhang Y, Ren J (2011) ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications. Pharmacol Ther 132(1):86–95
Zhang Y, Wang C, Zhou J, Sun A, Hueckstaedt LK, Ge J, Ren J (2017) Complex inhibition of autophagy by mitochondrial aldehyde dehydrogenase shortens lifespan and exacerbates cardiac aging. Biochim Biophys Acta Mol basis Dis 1863(8):1919–1932
Gong D, Zhang H, Hu S (2013) Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection. J Mol Cell Cardiol 55:58–63
Chen CH, Ferreira JC, Gross ER, Mochly-Rosen D (2014) Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev 94(1):1–34
Ma C, Yu B, Zhang W, Wang W, Zhang L, Zeng Q (2017) Associations between aldehyde dehydrogenase 2 (ALDH2) rs671 genetic polymorphisms, lifestyles and hypertension risk in Chinese Han people. Sci Rep 7(1):11136
Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto T, Kitagawa K, Nakayama KI, Hess DT, Stamler JS (2005) An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A 102(34):12159–12164
Ebert AD, Kodo K, Liang P, Wu H, Huber BC, Riegler J, Churko J, Lee J, de Almeida P, Lan F, Diecke S, Burridge PW, Gold JD, Mochly-Rosen D, Wu JC (2014) Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. Sci Transl Med 6(255):255ra130
Liu X, Sun X, Liao H, Dong Z, Zhao J, Zhu H, Wang P, Shen L, Xu L, Ma X, Shen C, Fan F, Wang C, Hu K, Zou Y, Ge J, Ren J, Sun A (2015) Mitochondrial aldehyde dehydrogenase 2 regulates revascularization in chronic ischemia: potential impact on the development of coronary collateral circulation. Arterioscler Thromb Vasc Biol 35(10):2196–2206
Sun A, Zou Y, Wang P, Xu D, Gong H, Wang S, Qin Y, Zhang P, Chen Y, Harada M, Isse T, Kawamoto T, Fan H, Yang P, Akazawa H, Nagai T, Takano H, Ping P, Komuro I, Ge J (2014) Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice. J Am Heart Assoc 3(5):e000779
Zhong W, Zhang W, Li Q, Xie G, Sun Q, Sun X, Tan X, Sun X, Jia W, Zhou Z (2015) Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice. J Hepatol 62(6):1375–1381
Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y, Shiraishi Y, Chiba K, Imoto S, Takahashi Y, Iwaya T, Sudo T, Hayashi T, Takai H, Kawasaki Y, Matsukawa T, Eguchi H, Sugimachi K, Tanaka F, Suzuki H, Yamamoto K, Ishii H, Shimizu M, Yamazaki H, Yamazaki M, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Mafune K, Tanaka Y, Kelsell DP, Scott CA, Tsuji S, Yachida S, Shibata T, Sugano S, Doki Y, Akiyama T, Aburatani H, Ogawa S, Miyano S, Mori M, Mimori K (2016) Genomic landscape of esophageal squamous cell carcinoma in a Japanese population. Gastroenterology 150(5):1171–1182
Zhu Y, Zhang D, Zhou D, Li Z, Li Z, Fang L, Yang M, Shan Z, Li H, Chen J, Zhou X, Ye W, Yu S, Li H, Cai L, Liu C, Zhang J, Wang L, Lai Y, Ruan L, Sun Z, Zhang S, Wang H, Liu Y, Xu Y, Ling J, Xu C, Zhang Y, Lv D, Yuan Z, Zhang J, Zhang Y, Shi Y, Lai M (2017) Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study. J Cell Mol Med 21(6):1106–1116
Zhang X, Ye YL, Wang YN, Liu FF, Liu XX, Hu BL, Zou M, Zhu JH (2015) Aldehyde dehydrogenase 2 genetic variations may increase susceptibility to Parkinson’s disease in Han Chinese population. Neurobiol Aging 36(9):2660.e2669–2660.e2613
Zhang Y, Mi SL, Hu N, Doser TA, Sun A, Ge J, Ren J (2014) Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function. Free Radic Biol Med 71:208–220
Booth LN, Brunet A (2016) The aging epigenome. Mol Cell 62(5):728–744
Fontana L, Kennedy BK, Longo VD, Seals D, Melov S (2014) Medical research: treat ageing. Nature 511(7510):405–407
Kubben N, Misteli T (2017) Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases. Nat Rev Mol Cell Biol 18(10):595–609
Benayoun BA, Pollina EA, Brunet A (2015) Epigenetic regulation of ageing: linking environmental inputs to genomic stability. Nat Rev Mol Cell Biol 16(10):593–610
Bilkei-Gorzo A (2014) Genetic mouse models of brain ageing and Alzheimer’s disease. Pharmacol Ther 142(2):244–257
Quiros PM, Langer T, Lopez-Otin C (2015) New roles for mitochondrial proteases in health, ageing and disease. Nat Rev Mol Cell Biol 16(6):345–359
He S, Sharpless NE (2017) Senescence in health and disease. Cell 169(6):1000–1011
Verdin E (2015) NAD(+) in aging, metabolism, and neurodegeneration. Science (New York, NY) 350(6265):1208–1213
Shay JW (2016) Role of telomeres and telomerase in aging and cancer. Cancer Discov 6(6):584–593
Falandry C, Bonnefoy M, Freyer G, Gilson E (2014) Biology of cancer and aging: a complex association with cellular senescence. J Clin Oncol Off J Am Soc Clin Oncol 32(24):2604–2610
Sies H (2015) Oxidative stress: a concept in redox biology and medicine. Redox Biol 4:180–183
Yee C, Yang W, Hekimi S (2014) The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C. elegans. Cell 157(4):897–909
Rogers LK, Cismowski MJ (2018) Oxidative stress in the lung – the essential paradox. Curr Opin Toxicol 7:37–43
Schottker B, Brenner H, Jansen EH, Gardiner J, Peasey A, Kubinova R, Pajak A, Topor-Madry R, Tamosiunas A, Saum KU, Holleczek B, Pikhart H, Bobak M (2015) Evidence for the free radical/oxidative stress theory of ageing from the CHANCES consortium: a meta-analysis of individual participant data. BMC Med 13:300
Garcia JJ, Lopez-Pingarron L, Almeida-Souza P, Tres A, Escudero P, Garcia-Gil FA, Tan DX, Reiter RJ, Ramirez JM, Bernal-Perez M (2014) Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res 56(3):225–237
Van Raamsdonk JM, Hekimi S (2012) Superoxide dismutase is dispensable for normal animal lifespan. Proc Natl Acad Sci U S A 109(15):5785–5790
Larsson NG (2010) Somatic mitochondrial DNA mutations in mammalian aging. Annu Rev Biochem 79:683–706
Finkel T (2015) The metabolic regulation of aging. Nat Med 21(12):1416–1423
Kim KH, Lee MS (2014) Autophagy – a key player in cellular and body metabolism. Nat Rev Endocrinol 10(6):322–337
Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148(6):1145–1159
Bratic A, Larsson NG (2013) The role of mitochondria in aging. J Clin Invest 123(3):951–957
Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5:253–295
Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434(7029):113–118
Riera CE, Dillin A (2015) Tipping the metabolic scales towards increased longevity in mammals. Nat Cell Biol 17(3):196–203
Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard BP, Mercken EM, Palmeira CM, de Cabo R, Rolo AP, Turner N, Bell EL, Sinclair DA (2013) Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155(7):1624–1638
Stenesen D, Suh JM, Seo J, Yu K, Lee KS, Kim JS, Min KJ, Graff JM (2013) Adenosine nucleotide biosynthesis and AMPK regulate adult life span and mediate the longevity benefit of caloric restriction in flies. Cell Metab 17(1):101–112
Li Q, Ceylan-Isik AF, Li J, Ren J (2008) Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction. Rejuvenation Res 11(4):725–733
Lu JY, Lin YY, Sheu JC, Wu JT, Lee FJ, Chen Y, Lin MI, Chiang FT, Tai TY, Berger SL, Zhao Y, Tsai KS, Zhu H, Chuang LM, Boeke JD (2011) Acetylation of yeast AMPK controls intrinsic aging independently of caloric restriction. Cell 146(6):969–979
Orogo AM, Gustafsson AB (2015) Therapeutic targeting of autophagy: potential and concerns in treating cardiovascular disease. Circ Res 116(3):489–503
Frankel LB, Lubas M, Lund AH (2017) Emerging connections between RNA and autophagy. Autophagy 13(1):3–23
Morel E, Mehrpour M, Botti J, Dupont N, Hamai A, Nascimbeni AC, Codogno P (2017) Autophagy: a druggable process. Annu Rev Pharmacol Toxicol 57:375–398
Delbridge LMD, Mellor KM, Taylor DJ, Gottlieb RA (2017) Myocardial stress and autophagy: mechanisms and potential therapies. Nat Rev Cardiol 14(7):412–425
Amaravadi R, Kimmelman AC, White E (2016) Recent insights into the function of autophagy in cancer. Genes Dev 30(17):1913–1930
Rubinsztein DC, Bento CF, Deretic V (2015) Therapeutic targeting of autophagy in neurodegenerative and infectious diseases. J Exp Med 212(7):979–990
Lapierre LR, Gelino S, Melendez A, Hansen M (2011) Autophagy and lipid metabolism coordinately modulate life span in germline-less C. elegans. Curr Biol 21(18):1507–1514
Vidal RL, Matus S, Bargsted L, Hetz C (2014) Targeting autophagy in neurodegenerative diseases. Trends Pharmacol Sci 35(11):583–591
Ktistakis NT, Tooze SA (2016) Digesting the expanding mechanisms of autophagy. Trends Cell Biol 26(8):624–635
Chandra V, Bhagyaraj E, Parkesh R, Gupta P (2016) Transcription factors and cognate signalling cascades in the regulation of autophagy. Biol Rev Camb Philos Soc 91(2):429–451
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O’Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P (2018) Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 137(12):e67–e492
Camici GG, Savarese G, Akhmedov A, Luscher TF (2015) Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease. Eur Heart J 36(48):3392–3403
Shirakabe A, Ikeda Y, Sciarretta S, Zablocki DK, Sadoshima J (2016) Aging and autophagy in the heart. Circ Res 118(10):1563–1576
Nakayama H, Nishida K, Otsu K (2016) Macromolecular degradation systems and cardiovascular aging. Circ Res 118(10):1577–1592
Wenzel P, Schuhmacher S, Kienhofer J, Muller J, Hortmann M, Oelze M, Schulz E, Treiber N, Kawamoto T, Scharffetter-Kochanek K, Munzel T, Burkle A, Bachschmid MM, Daiber A (2008) Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovasc Res 80(2):280–289
Hua Y, Zhang Y, Ceylan-Isik AF, Wold LE, Nunn JM, Ren J (2011) Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy. Basic Res Cardiol 106(6):1173–1191
Park JW, Ji YI, Choi YH, Kang MY, Jung E, Cho SY, Cho HY, Kang BK, Joung YS, Kim DH, Park SC, Park J (2009) Candidate gene polymorphisms for diabetes mellitus, cardiovascular disease and cancer are associated with longevity in Koreans. Exp Mol Med 41(11):772–781
Mizuno Y, Hokimoto S, Harada E, Kinoshita K, Nakagawa K, Yoshimura M, Ogawa H, Yasue H (2016) Variant aldehyde dehydrogenase 2 (ALDH2*2) is a risk factor for coronary spasm and ST-segment elevation myocardial infarction. J Am Heart Assoc 5(5):e003247
Mizuno Y, Harada E, Morita S, Kinoshita K, Hayashida M, Shono M, Morikawa Y, Murohara T, Nakayama M, Yoshimura M, Yasue H (2015) East Asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: possible roles of reactive aldehydes and implications of alcohol flushing syndrome. Circulation 131(19):1665–1673
Dassanayaka S, Zheng Y, Gibb AA, Cummins TD, McNally LA, Brittian KR, Jagatheesan G, Audam TN, Long BW, Brainard RE, Jones SP, Hill BG (2018) Cardiac-specific overexpression of aldehyde dehydrogenase 2 exacerbates cardiac remodeling in response to pressure overload. Redox Biol 17:440–449
Wyss-Coray T (2016) Ageing, neurodegeneration and brain rejuvenation. Nature 539(7628):180–186
Gan L, Cookson MR, Petrucelli L, La Spada AR (2018) Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci 21(10):1300–1309
D’Souza Y, Elharram A, Soon-Shiong R, Andrew RD, Bennett BM (2015) Characterization of Aldh2 (−/−) mice as an age-related model of cognitive impairment and Alzheimer’s disease. Mol Brain 8:27
Ohsawa I, Nishimaki K, Murakami Y, Suzuki Y, Ishikawa M, Ohta S (2008) Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity. J Neurosci Off J Soc Neurosci 28(24):6239–6249
Kim JM, Stewart R, Shin IS, Jung JS, Yoon JS (2004) Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer’s disease in an older Korean population. Neurobiol Aging 25(3):295–301
Hou G, Chen L, Liu G, Li L, Yang Y, Yan HX, Zhang HL, Tang J, Yang YC, Lin X, Chen X, Luo GJ, Zhu Y, Tang S, Zhang J, Liu H, Gu Q, Zhao LH, Li Y, Liu L, Zhou W, Wang H (2017) Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice. Hepatology (Baltimore, Md) 65(5):1628–1644
Ishioka K, Masaoka H, Ito H, Oze I, Ito S, Tajika M, Shimizu Y, Niwa Y, Nakamura S, Matsuo K (2018) Association between ALDH2 and ADH1B polymorphisms, alcohol drinking and gastric cancer: a replication and mediation analysis. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 21:936–945
Jin S, Chen J, Chen L, Histen G, Lin Z, Gross S, Hixon J, Chen Y, Kung C, Chen Y, Fu Y, Lu Y, Lin H, Cai X, Yang H, Cairns RA, Dorsch M, Su SM, Biller S, Mak TW, Cang Y (2015) ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis. Proc Natl Acad Sci U S A 112(29):9088–9093
van den Beld AW, Kaufman JM, Zillikens MC, Lamberts SWJ, Egan JM, van der Lely AJ (2018) The physiology of endocrine systems with ageing. Lancet Diabetes Endocrinol 6(8):647–658
Wang C, Fan F, Cao Q, Shen C, Zhu H, Wang P, Zhao X, Sun X, Dong Z, Ma X, Liu X, Han S, Wu C, Zou Y, Hu K, Ge J, Sun A (2016) Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice. J Mol Med (Berlin, Germany) 94(11):1229–1240
Veldurthy V, Wei R, Oz L, Dhawan P, Jeon YH, Christakos S (2016) Vitamin D, calcium homeostasis and aging. Bone Res 4:16041
Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Pignone M, Silverstein M, Simon MA, Tseng CW, Wong JB (2018) Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA 319(24):2521–2531
Yamaguchi J, Hasegawa Y, Kawasaki M, Masui T, Kanoh T, Ishiguro N, Hamajima N (2006) ALDH2 polymorphisms and bone mineral density in an elderly Japanese population. Osteoporos Int 17(6):908–913
Acknowledgments
This work was supported in part by NSFC91749128. We wish to express our apology for those authors whose important work was unable to be included due to space limitation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wu, N.N., Ren, J. (2019). Aldehyde Dehydrogenase 2 (ALDH2) and Aging: Is There a Sensible Link?. In: Ren, J., Zhang, Y., Ge, J. (eds) Aldehyde Dehydrogenases. Advances in Experimental Medicine and Biology, vol 1193. Springer, Singapore. https://doi.org/10.1007/978-981-13-6260-6_15
Download citation
DOI: https://doi.org/10.1007/978-981-13-6260-6_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6259-0
Online ISBN: 978-981-13-6260-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)